January 21st 2016

MAPPs newsletter NEW HEADER

E-NEWSLETTER 3rd March 2016
Medicines Adaptive Pathways to Patients (MAPPs) are the ongoing development of new clinical pathways that respond to the continually improving understanding of diseases and growing number of data sources, with the goal of providing better planned access without lowering evidence standards.

In this newsletter, Susan Forda of Eli Lilly writes on what sets PRIME apart from similar initiatives with the same aim, while also looking at the progress that has been made in efforts to advance access to innovative therapies thus far. 

Meanwhile, the commentary article "Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to Implementation” provides a background on the evolution of adaptive pathways, from inception of the idea to the EMA pilot, and offers insight into the path that led up to initiatives like PRIME finding successful adoption by the EMA.
Sue Forda

Article by Susan Forda, Vice President, International Regulatory Affairs Eli Lilly and Company: "EMA's PRIME can help speed delivery of new medicines to patients"

The European Medicines Agency's PRIME (Priority Medicines) intiative is a welcome step towards connecting healthcare decision-makers to expedite patient access to new medicines - but what sets it apart from from other mechanisms with similar aims? Susan Forda discusses what sets PRIME apart and examines what elements are needed to make PRIME a success, not only in principle, but also in practice.

littlesq littlesq
Article "Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to Implementation"

The commentary article "Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to Implementation" has been published in the Drug Information Association's journal TIRS (Therapeutic Innovation & Regulatory Science). The article includes input from EFPIA's MAPPs Taskforce members.


Upcoming Events
littlesq littlesq

GetReal 2
MAPPs-Relevant Events

In order for MAPPs to be successful, it will require the development of many needed tools and enablers for implementation – including the harnessing of real world evidence. The IMI projects GetReal and EMIF are testing the practical use of real world evidence to facilitate better decision making for Adaptive Pathways.

EMIF: E-managing the Future of Health Data (16-17 March 2016 - Budapest - By Invitation Only): How do we maximise the benefits offered by harnessing available health data, while solving issues around its reuse, and work with regulators to provide the right evidence? 
More Information and Link to Request Your Invitation

IMI GetReal Webinar: Work Package 1 - Effectivenes Research: navigating real world approaches (23 March 2016 - 12:00 - 13:00 CET): This webinar will provide the opportunity for participants to receive the latest updates on key outputs from the IMI GetReal project. 
More Information and Registration Link
EFPIA Brussels Office
littlesq littlesq
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: anna.szczepanska@efpia.eu or science-policy@efpia.eu 




Click to view this email in a browser

If you no longer wish to receive these emails, please reply to this message with "Unsubscribe" in the subject line or simply click on the following link: Unsubscribe

Vital Transformation
107 Leopold III Laan
Wezembeek-Oppem, 1970

Read the VerticalResponse marketing policy.

Try Email Marketing with VerticalResponse!